| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/15/2005 | CN1626086A Urapidil powder and injection preparation and preparing method |
| 06/15/2005 | CN1626085A Levosimendan freeze-dried preparation and preparing method |
| 06/15/2005 | CN1626084A Combination of antibacterials and usage |
| 06/15/2005 | CN1626083A Powder and injection preparation of hydrochloric naloxone and preparation method |
| 06/15/2005 | CN1626082A Nano particles of polyglycol-poly(lactide-caprolactone) of carrying camptothecin and preparation method |
| 06/15/2005 | CN1626081A Ropivacaine freeze-dried powder and injection preparation in use for injection and preparation method |
| 06/15/2005 | CN1626080A Paracetamol Pseudoephedrine desintegration piece and preparation method |
| 06/15/2005 | CN1626079A Fibrauretine injection preparation and preparing method |
| 06/15/2005 | CN1626078A Tindazole powder and injection preparation and preparation method |
| 06/15/2005 | CN1626077A Treatment of nuerodegenerative diseases |
| 06/15/2005 | CN1626076A Andrographolide drop pills and preparation method |
| 06/15/2005 | CN1626075A Combination of medication and application of preparing medication for treating or preventing cardiovascular and cerebrovascular diseases |
| 06/15/2005 | CN1626074A Preparation of Chinese traditional medicine |
| 06/15/2005 | CN1626073A Medication for treating oral disease |
| 06/15/2005 | CN1626072A Powder and injection preparation of new houttuynine sodium bisulfite and preparation method |
| 06/15/2005 | CN1626071A Propylgallate injection administration does type and preparation method |
| 06/15/2005 | CN1626070A Effect of aminoguanidine for curing wound surface in refractory to treatment |
| 06/15/2005 | CN1626069A Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy |
| 06/15/2005 | CN1626068A Combination of medication in use for improving dissolution of curcumin and bioavailability as well as preparation method |
| 06/15/2005 | CN1626067A Preparation of honokiol, magnolol or their admixture and usage in preparing medication for treating cardiovascular and cerebrovascular diseases |
| 06/15/2005 | CN1206535C Modulating multiple lineage kinase proteins |
| 06/15/2005 | CN1206363C Process for obtaining of HMG-CO a reductase inhibitors of high purify |
| 06/15/2005 | CN1206236C Manyprickle acanthopanax general saponin extractive and its medicinal composition |
| 06/15/2005 | CN1206231C 7-acylamino-3-heteroarylthio-3-cephem carboxylic and prodrugs thereof |
| 06/15/2005 | CN1206230C 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 06/15/2005 | CN1206228C N-heterocyclic derivatives as NOS inhibitors |
| 06/15/2005 | CN1206221C Acridine derivatives |
| 06/15/2005 | CN1206219C N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/15/2005 | CN1206213C N-arylsulfonyl amino acid omega amides |
| 06/15/2005 | CN1206212C Tri-substd. phenyl derivs. and analogues |
| 06/15/2005 | CN1206210C Ethyl methyl 3-[(1S)-1-(dimethylamino)ethyl]phenyl] carbamate and its prepn and medicine use |
| 06/15/2005 | CN1206207C Preparation method of cyanophthaofluoroaniline |
| 06/15/2005 | CN1206133C Infusion packet and its use |
| 06/15/2005 | CN1205999C Liposone composition and method for administration of a radiosensitizer |
| 06/15/2005 | CN1205998C Antigen-specific IgE antibody production inhibitors |
| 06/15/2005 | CN1205997C Method of increasing bone toughness and stiffness and reducing fractures |
| 06/15/2005 | CN1205994C Pulmonary delivery of active agents |
| 06/15/2005 | CN1205988C Medicine for treating hepatitis |
| 06/15/2005 | CN1205986C Compound psorolea tincture for treating leukoderma |
| 06/15/2005 | CN1205972C Chinese medicnie preparation for preventing and treating throat and oral cavity diseases and preparation method |
| 06/15/2005 | CN1205969C Ointment of Chinese traditional medicine for curing fever and cough |
| 06/15/2005 | CN1205964C Medicament for curing colpitismycotica and trichomonal vaginitis and its preparation method |
| 06/15/2005 | CN1205961C Ointment for external application for curing scald and burn |
| 06/15/2005 | CN1205959C Plaster for treating arthritis and cervical vertebra and vertebra lumbalis diseases |
| 06/15/2005 | CN1205954C Hair restorer and its prepn. method |
| 06/15/2005 | CN1205951C Composite medicine for treating hircus, tinea and external piles |
| 06/15/2005 | CN1205949C Externally applied ointment for treating prostatosis and its prepn |
| 06/15/2005 | CN1205943C Application of citrus paradisi Micf seed in preparing medicine for resisting SARS virus |
| 06/15/2005 | CN1205942C Archimycin gel for eye application |
| 06/15/2005 | CN1205941C Puerarin oral preparation and its preparation method |
| 06/15/2005 | CN1205940C Erigeron breviscapus slow release capsule and its preparation method |
| 06/15/2005 | CN1205939C Use of total polygalin in preparing medicine for promoting gastrointestinal peristalsis |
| 06/15/2005 | CN1205938C Products having function of improving microcirculation action of mammal |
| 06/15/2005 | CN1205937C Phosphatidic acid-comprising compositions |
| 06/15/2005 | CN1205936C Novel contraceptive medicament and method for producing the same |
| 06/15/2005 | CN1205935C Highly selective norepinephrine reuptake inhibitors and methods of using same |
| 06/15/2005 | CN1205934C Composition for treating hyperlipemia |
| 06/15/2005 | CN1205933C Slow-releasing acipimox capsule |
| 06/15/2005 | CN1205932C Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury |
| 06/15/2005 | CN1205931C Pharmaeutical agent comprising benzamide derivative as active ingredient |
| 06/15/2005 | CN1205930C Application of matrine oxide in preparing medicine for treating nephrotic syndrome hemorrhagic fevor |
| 06/15/2005 | CN1205929C Local administration preparation |
| 06/15/2005 | CN1205928C Application of xanthiphenylketamine or its salt in preparing medicines to treat cardiovascular disease |
| 06/15/2005 | CN1205927C Water soluble trioxanes as potent and safe anti-malarial agents |
| 06/15/2005 | CN1205926C Agents for combating neospora spec |
| 06/15/2005 | CN1205923C Liposome-entrapped topoisomerase inhibitors |
| 06/15/2005 | CN1205922C Preparation of aqueous clear solution dosage forms with bile acids |
| 06/15/2005 | CN1205921C Long acting injectable formulations contg. hydrogenated castor oil |
| 06/15/2005 | CN1205914C Cosmetic composition |
| 06/14/2005 | US6906210 Method for producing lipoic acid and dihydrolipoic acid |
| 06/14/2005 | US6906205 Spiro and dispiro 1,2,4-trioxolane antimalarials |
| 06/14/2005 | US6906204 Processing method of lactionization in the preparation of statins |
| 06/14/2005 | US6906203 Anticancer agents; such as 2-Amino-3-cyano-4-(2-bromo-4,5-dimethoxyphenyl)-4H-indolo(4,5-b)pyran |
| 06/14/2005 | US6906202 Purified racemic lasofoxifene and purified lasofoxifene D-tartrate and a method for effective purification of racemic lasofoxifene |
| 06/14/2005 | US6906199 Process for preparing distamycin derivatives |
| 06/14/2005 | US6906196 Antiinflammatory agents, rheumatic disorders |
| 06/14/2005 | US6906193 N-type calcium channel antagonists for the treatment of pain |
| 06/14/2005 | US6906190 Inhibitors for de novo-RNA polymerases and methods of identifying targets for same |
| 06/14/2005 | US6906184 Catalytic hydrogenation in solvent; oxidation |
| 06/14/2005 | US6906182 Inhibiting abnormal cellular proliferation in a mammal; and a method of inhibiting replication of a virus in a mammal. |
| 06/14/2005 | US6906175 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor. |
| 06/14/2005 | US6906174 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 06/14/2005 | US6906107 Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria |
| 06/14/2005 | US6906106 Compositions for the skin comprising fibers and ubiquinones and methods of using the same |
| 06/14/2005 | US6906104 Aminediols for the treatment of Alzheimer's disease |
| 06/14/2005 | US6906103 Compounds possessing antibacterial, antifungal or antitumor activity |
| 06/14/2005 | US6906102 Use of isovaleryl L-carnitine to increase healing of bone fractures |
| 06/14/2005 | US6906101 Taxane derivatives and processes for the preparation thereof |
| 06/14/2005 | US6906100 Optionally esterified 5-ethylidene-4-carboxy-2-pyranones as a cytoprotective agent |
| 06/14/2005 | US6906099 By administering a drug that increases central nervous system GABA (4-aminobutyric acid) levels; for example gabapentin, valproic acid, progabide, gamma- hydroxybutyric acid, fengabine, cetylGABA, topiramate, tiagabine, or acamprosate |
| 06/14/2005 | US6906097 A 7-(5-oxo-pyrrolidin-1-yl)-heptanoic acid or ester derivatives for therapeutic treatment of eye hypertension or glaucoma |
| 06/14/2005 | US6906094 1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase |
| 06/14/2005 | US6906092 Method of inhibiting matrix metalloproteinases |
| 06/14/2005 | US6906091 Inhibiting metastasis with a 2-(alkoxycarbonylamino)benzimidazole prodrug |
| 06/14/2005 | US6906090 Compositions and methods for treating mycobacterial diseases |
| 06/14/2005 | US6906089 Kidney disease; cardiovascular disorders; antiscarring agents; wound healing agents |
| 06/14/2005 | US6906088 Taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions; anticarcinogenic agent |
| 06/14/2005 | US6906087 Antidepressant; storage stability |
| 06/14/2005 | US6906086 Methods for inhibiting bone loss |
| 06/14/2005 | US6906085 Tetrahydropyran derivatives as neurokinin receptor antagonists |